ICMR begins trials on Covid-19 patients to test plasma therapy's efficacy

Plan is to have 20-25 such trials across India under the apex health research institute

The Indian Council of Medical Research has commissioned clinical trials on patients across public hospitals to test the safety and efficacy of convalescent plasma therapy, in what can soon be recommended as a possible line of treatment.
 

One such trial sponsored by the ICMR is set to begin on 20 patients in Ahmedabad. The plan is to have 20-25 such trials across India.
 

Currently, there are no approved treatments for Covid-19. The disease is being managed with supplemental oxygen and mechanical ventilation apart from treatment offered on case-to-case basis depending on co-morbidities.

This lack of a clear line of